Aptus Pharma Ltd
Aptus Pharma Ltd Share Price Today: Live Updates & Key Insights
Get insights on Aptus Pharma Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Aptus Pharma Ltd Share Price Chart
APPL at 10 Jul 2026 06:47 PM Pharmaceuticals
224.00 +4.25(+1.93%)
Lowest Today 215.50
Highest Today 224.00
Today's Open 215.50
Prev. Close 219.75
52 Week High 446.80
52 Week Low 80.80
Aptus Pharma Ltd Fundamentals
Traded Volume: 9,600
Market Cap(Cr): 384.16
Avg Traded Price 219.41
1 Year return %
Upper Circuit 224
Lower Circuit 215.5
P/E TTM 0.00
P/B Ratio 6.458
Traded Value(Cr) 21.50
EPS TTM NaN
Book value/Share 34.030
Dividend Yield 1Y 0.00%
Aptus Pharma Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Aptus Pharma Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Aptus Pharma Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y 0.00%
YTD 0.00%
Aptus Pharma Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Aptus Pharma Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Aptus Pharma Ltd Technical Details
Aptus Pharma Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 218
Support 2 213
Support 3 210
Pivot Point : 221
Resistance 1 227
Resistance 2 230
Resistance 3 235
Aptus Pharma Ltd Corporate Actions
Aptus Pharma Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Aptus Pharma Ltd’s capital allocation strategies.
All
Ex-Date 12-May-2026 Type B Description share@3:2 Record Date 12-May-2026 Ratio 3:2
Dividends
No Dividend has been declared by APPL
Bonus
Record Date 12-May-2026 Ex-Bonus Date 12-May-2026 Ratio 3:2
Splits
No Split has been declared by APPL
Others
Rights No Rights has been declared by APPL
Aptus Pharma Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Aptus Pharma Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Aptus Pharma Ltd's relative performance and valuation against major competitors.
Stock Name Bafna Pharmaceuticals Ltd ₹204.61 (+2.00%) M. Cap (Cr) 4.84 1 Yr Return (%) +140.32% P/E (TTM) 43.61 PB Ratio 5.03
Stock Name Haleos Labs Limited ₹1596.60 (+3.22%) M. Cap (Cr) 4.83 1 Yr Return (%) +31.82% P/E (TTM) 27.88 PB Ratio 2.26
Stock Name Albert David Ltd ₹701.00 (+0.65%) M. Cap (Cr) 4.00 1 Yr Return (%) -23.91% P/E (TTM) -267.66 PB Ratio 1.02
Stock Name Aptus Pharma Ltd ₹224.00 (+1.93%) M. Cap (Cr) 3.84 1 Yr Return (%) NaN% P/E (TTM) 83.15 PB Ratio 16.45
Stock Name Valiant Laboratories Ltd ₹62.08 (-0.13%) M. Cap (Cr) 3.37 1 Yr Return (%) -41.98% P/E (TTM) -102.91 PB Ratio 1.08
Stock Name Medicamen Biotech Ltd ₹245.35 (-0.02%) M. Cap (Cr) 3.33 1 Yr Return (%) -37.94% P/E (TTM) 30.63 PB Ratio 1.21
Stock Name Medico Remedies Ltd ₹39.71 (+1.59%) M. Cap (Cr) 3.30 1 Yr Return (%) -5.36% P/E (TTM) 25.13 PB Ratio 4.37
Aptus Pharma Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Aptus Pharma Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -6.86 Mar 2025 -1.84 Mar 2024 -2.17 Mar 2023 -0.18
PARTICULARS Investing Activities Mar 2026 -6.37 Mar 2025 -0.54 Mar 2024 -0.30 Mar 2023 -0.35
PARTICULARS Financing Activities Mar 2026 9.04 Mar 2025 6.68 Mar 2024 2.86 Mar 2023 0.81
PARTICULARS Net Cash Flow Mar 2026 -4.19 Mar 2025 4.30 Mar 2024 0.38 Mar 2023 0.28
Aptus Pharma Ltd Shareholding Pattern
This shows the ownership breakdown of Aptus Pharma Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Aptus Pharma Ltd
Aptus Pharma Limited was originally incorporated as Aptus Pharma Private Limited, as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010. Subsequently, Company was converted into a public limited retaining the name as Aptus Pharma Limited and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre.Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements. It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.The Company started business through 4 regional headquarters in Gujarat in 2011. It launched a portfolio of nearly 25 products targeting essential therapeutic divisions in 2013. It expanded the operations to over 50 products, catering to both acute and chronic segments in 2015. This resulted the increase in portfolio to 70 products in 2019 and to over 100 in 2022. The Company enhanced the production to over 175 products in 2024. It established 3 operational divisions: Acute, Chronic, and OTC in 2024. Company is planning the Initial Public Issue of 20,00,000 equity shares of face value of Rs 10 each through fresh issue.
Registered office Ashutosh Buildcon Asali, Daskroi, Ahmedabad, Gujarat, 382427
FAX :+91 76004 27827
Background
Incorporation Year 2010
Face Value ₹10.00
Market Lot 5000
FAQs on Aptus Pharma Ltd
How to buy Aptus Pharma Ltd shares?
To buy Aptus Pharma Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Aptus Pharma Ltd?
The company has a market capitalization of ₹384.16.
What is the PE & PB ratio of Aptus Pharma Ltd?
PE is N/A and PB is 6.458.
What is the Aptus Pharma Ltd dividend for 2025–26?
For the 2025–26 financial year, Aptus Pharma Ltd declared a final dividend of null% per share.